Literature DB >> 7993982

Percutaneous absorption of diclofenac in healthy volunteers after single and repeated topical application of diclofenac Emulgel.

A Sioufi1, F Pommier, F Boschet, J Godbillon, D Lavoignat, D Salliere.   

Abstract

The percutaneous absorption of diclofenac was studied in ten healthy volunteers treated with Emulgel containing 1.16% diclofenac diethylammonium for 8 d as follows: a single application of 5 g Emulgel on days 1 and 8, and two applications d-1 on days 2-7. Plasma concentration profiles of unchanged diclofenac and urinary concentrations of total diclofenac and metabolites (sum of free and conjugated) were determined. High inter-individual variations in plasma and urine data were recorded, due probably to the permeability and the hydration of the skin. Steady state was reached after 2 d of twice-daily administration. Plasma concentrations were low but remained in the range 10-50 nmol L-1 over the full day for most of the subjects, indicating prolonged absorption from the application site.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7993982     DOI: 10.1002/bdd.2510150602

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  15 in total

Review 1.  Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls.

Authors:  N M Davies; K E Anderson
Journal:  Clin Pharmacokinet       Date:  1997-09       Impact factor: 6.447

2.  Evaluation of glycofurol-based gel as a new vehicle for topical application of naproxen.

Authors:  Nahla Salah Barakat
Journal:  AAPS PharmSciTech       Date:  2010-07-23       Impact factor: 3.246

3.  Diclofenac metabolic profile following in vitro percutaneous absorption through viable human skin.

Authors:  H Tanojo; R C Wester; J Z Shainhouse; H I Maibach
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Oct-Dec       Impact factor: 2.441

Review 4.  Topical therapies for osteoarthritis.

Authors:  Roy D Altman; H Richard Barthel
Journal:  Drugs       Date:  2011-07-09       Impact factor: 9.546

Review 5.  Oral versus topical NSAIDs in rheumatic diseases: a comparison.

Authors:  C A Heyneman; C Lawless-Liday; G C Wall
Journal:  Drugs       Date:  2000-09       Impact factor: 9.546

6.  In vivo bioavailability and metabolism of topical diclofenac lotion in human volunteers.

Authors:  X Hui; P G Hewitt; N Poblete; H I Maibach; J Z Shainhouse; R C Wester
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

7.  [Pulmonary infiltrates with blood eosinophilia in a 62-year-old patient].

Authors:  M Kohlhäufl; N Weber; A Morresi-Hauf; D Geiger; H Raith; K Häussinger
Journal:  Internist (Berl)       Date:  2003-08       Impact factor: 0.743

8.  Diclofenac systemic exposure is not increased when topical diclofenac is applied to ultraviolet-induced erythema.

Authors:  J-L Magnette; J-L Kienzler; D Sallin; C Ménart; F Nollevaux; A Knops
Journal:  Eur J Clin Pharmacol       Date:  2004-09-29       Impact factor: 2.953

9.  In vitro cutaneous disposition of a topical diclofenac lotion in human skin: effect of a multi-dose regimen.

Authors:  P G Hewitt; N Poblete; R C Wester; H I Maibach; J Z Shainhouse
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

Review 10.  Diclofenac epolamine (Flector) patch: evidence for topical activity.

Authors:  Birte Petersen; Stefano Rovati
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.